MUCCIOLI, LORENZO
 Distribuzione geografica
Continente #
AS - Asia 4.041
NA - Nord America 3.422
EU - Europa 2.260
Continente sconosciuto - Info sul continente non disponibili 237
SA - Sud America 232
AF - Africa 197
OC - Oceania 4
Totale 10.393
Nazione #
US - Stati Uniti d'America 3.290
VN - Vietnam 1.100
SG - Singapore 972
IT - Italia 952
CN - Cina 908
HK - Hong Kong 267
SE - Svezia 262
DE - Germania 226
BD - Bangladesh 183
NL - Olanda 168
BR - Brasile 164
GB - Regno Unito 161
KR - Corea 160
IN - India 137
FR - Francia 114
CI - Costa d'Avorio 90
RU - Federazione Russa 79
IE - Irlanda 74
CA - Canada 68
JP - Giappone 67
FI - Finlandia 51
JO - Giordania 43
ID - Indonesia 35
PH - Filippine 34
BG - Bulgaria 28
TH - Thailandia 26
AT - Austria 25
ZA - Sudafrica 25
MX - Messico 23
NG - Nigeria 23
CH - Svizzera 21
IQ - Iraq 20
AR - Argentina 19
TR - Turchia 19
CO - Colombia 16
TG - Togo 15
EC - Ecuador 14
PK - Pakistan 14
SC - Seychelles 14
ES - Italia 13
JM - Giamaica 13
UA - Ucraina 13
TW - Taiwan 12
PL - Polonia 11
BE - Belgio 9
GR - Grecia 9
CR - Costa Rica 7
SA - Arabia Saudita 7
UZ - Uzbekistan 6
EE - Estonia 5
LT - Lituania 5
RO - Romania 5
VE - Venezuela 5
AU - Australia 4
AZ - Azerbaigian 4
CL - Cile 4
DK - Danimarca 4
EG - Egitto 4
HR - Croazia 4
IL - Israele 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
CG - Congo 3
CM - Camerun 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
HN - Honduras 3
LB - Libano 3
NI - Nicaragua 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
SV - El Salvador 3
TN - Tunisia 3
BH - Bahrain 2
DZ - Algeria 2
GH - Ghana 2
IR - Iran 2
IS - Islanda 2
KE - Kenya 2
KZ - Kazakistan 2
LV - Lettonia 2
PR - Porto Rico 2
SI - Slovenia 2
SO - Somalia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
DJ - Gibuti 1
HU - Ungheria 1
Totale 10.145
Città #
Singapore 699
Ashburn 448
Hefei 336
Ho Chi Minh City 303
Hanoi 264
Hong Kong 254
San Jose 248
Bologna 171
Chandler 158
Seoul 152
Council Bluffs 136
Santa Clara 129
Beijing 100
Fairfield 97
Southend 95
Milan 93
Los Angeles 91
Abidjan 90
Dallas 90
New York 90
Boardman 85
Dublin 74
Houston 58
Tokyo 58
Ann Arbor 55
Princeton 55
Lauterbourg 51
Seattle 51
Rome 48
Dong Ket 44
Wilmington 44
Woodbridge 44
Amman 43
Cambridge 42
Haiphong 39
Chicago 38
Turin 38
Da Nang 36
Florence 35
Modena 35
Phoenix 33
Munich 32
São Paulo 32
Bengaluru 30
Redondo Beach 29
Frankfurt am Main 28
Helsinki 28
Sofia 27
Amsterdam 26
Buffalo 23
Fort Wayne 23
Nuremberg 23
Abeokuta 21
Redmond 20
Naples 19
Bern 18
Jakarta 18
Johannesburg 18
Hải Dương 17
London 17
Montreal 17
Shanghai 17
Vienna 17
Biên Hòa 16
Lappeenranta 16
Rimini 16
Thái Nguyên 16
Atlanta 15
Lomé 15
Des Moines 14
Ha Long 14
Quận Bình Thạnh 14
Bắc Giang 13
Düsseldorf 13
Washington 13
Berlin 12
San Francisco 12
Tongling 12
Bangkok 11
Hyderabad 11
Jinan 11
Mexico City 11
Orem 11
San Diego 11
Bắc Ninh 10
Guangzhou 10
Kuban 10
Miami 10
Toronto 10
Điện Bàn 10
Boston 9
Brooklyn 9
Brussels 9
Kingston 9
Las Vegas 9
Paris 9
The Dalles 9
Boydton 8
Charlotte 8
Denver 8
Totale 5.974
Nome #
Prognostic value of pathogenic variants in Lafora Disease: systematic review and meta-analysis of patient-level data 409
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy 233
Ictal Bradycardia and Asystole in Sleep-Related Hypermotor Epilepsy: A Study of 200 Patients 230
CAR t-cell therapy in BOlogNa–NEUrotoxicity TReatment and Assessment in Lymphoma (CARBON–NEUTRAL): proposed protocol and results from an Italian study 225
Epilepsy With Auditory Features: From Etiology to Treatment 225
Epilepsy with auditory features: Contribution of known genes in 112 patients 216
Genome-wide identification and phenotypic characterization of seizure-associated copy number variations in 741,075 individuals 212
Acute-onset focal neurological deficits in rheumatoid arthritis: Consider rheumatoid meningitis 212
Epilepsy with auditory features: Long-term outcome and predictors of terminal remission 209
FDG-PET assessment and metabolic patterns in Lafora disease 207
Juvenile absence epilepsy relapsing as recurrent absence status, mimicking transient global amnesia, in an elderly patient 204
Encephalopathy in COVID-19 Presenting With Acute Aphasia Mimicking Stroke 204
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 202
VAL-1221 for the treatment of patients with Lafora disease: Study protocol for a single-arm, open-label clinical trial 198
Relationship between plasma concentrations and clinical effects of perampanel: A prospective observational study 197
Neurological Manifestations of Long {COVID}: A Single-Center One-Year Experience 196
Ictal vasodepressive syncope in temporal lobe epilepsy 196
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 188
Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 188
Treatment with metformin in twelve patients with Lafora disease 187
EEG findings in COVID-19 related encephalopathy 185
Peripheral nervous system adverse events associated with immune checkpoint inhibitors 182
A case of clinical worsening after stereo-electroencephalographic-guided radiofrequency thermocoagulation in a patient with polymicrogyria 177
Risk of hospitalization and death for COVID-19 in persons with epilepsy over a 20-month period: The EpiLink Bologna cohort, Italy 177
Epilepsy and inborn errors of metabolism in adults: The diagnostic odyssey of a young woman with medium-chain acyl-coenzyme A dehydrogenase deficiency 172
Complete Agenesis of Corpus Callosum in KCNQ2-Related Neonatal Epileptic Encephalopathy 170
Secondary sclerosing cholangitis in critically ill patients with febrile infection-related epilepsy syndrome (FIRES): a case series 160
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment 160
The Impact of the COVID-19 Pandemic on People With Epilepsy. An Italian Survey and a Global Perspective 159
Erratum: Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals (The American Journal of Human Genetics (2021) 108(6) (965–982), (S0002929721001403), (10.1016/j.ajhg.2021.04.009)) 157
If seizures left speechless: CA-P-S C-A-R-E, a proposal of a new ictal language evaluation protocol 154
Polygenic burden in focal and generalized epilepsies 152
MECP2 duplication syndrome: The electroclinical features of a case with long-term evolution 151
Super refractory status epilepticus in Lafora disease interrupted by vagus nerve stimulation: A case report 146
Pseudohyperkalemia due to cryohydrocytosis in GLUT1 deficiency syndrome. A case report and literature review 144
Anti-LGI1 encephalitis following COVID-19 vaccination: a case series 142
Akinetic mutism in COVID-19-related encephalopathy: A cytokine-mediated maladaptive sickness behavioral response? 142
SCN1A mutations in focal epilepsy with auditory features: widening the spectrum of GEFS plus 141
COVID-19–Associated Encephalopathy and Cytokine-Mediated Neuroinflammation 139
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 133
Cognitive and functional connectivity impairment in post-COVID-19 olfactory dysfunction 130
Natural history of Lafora disease: a prognostic systematic review and individual participant data meta-analysis 129
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy 127
Exome sequencing of 20,979 individuals with epilepsy reveals shared and distinct ultra-rare genetic risk across disorder subtypes 125
Brain dysfunction in COVID-19 and CAR-T therapy: cytokine storm-associated encephalopathy 113
Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals 105
Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study 104
Low CSF hypocretin-1 levels in an adult patient with hypothalamic hamartoma 101
Carotid free-floating thrombus in COVID-19: a cerebrovascular disorder of cytokine storm-related immunothrombosis 100
Clinical course and management challenges in Lafora disease: a narrative analysis in an Apulian cohort 98
Fulminant cerebral edema following CAR T-cell therapy: case report and pathophysiological insights from literature review 97
Genome-wide meta-analysis of over 29,000 people with epilepsy reveals 26 loci and subtype-specific genetic architecture 96
Standard complete blood count to predict long-term outcomes in febrile infection–related epilepsy syndrome (FIRES): A multicenter study 95
Real-world experience with cannabidiol as add-on treatment in drug-resistant epilepsy 95
The In Vivo Diagnosis of Concomitant Alzheimer and Lewy Body Pathology: A Case Report 93
Subcortical Myoclonus in Coronavirus Disease 2019: Comprehensive Evaluation of a Patient 91
Subacute-onset paraneoplastic autonomic neuropathy associated with prostate cancer 87
EEG as a predictive biomarker of neurotoxicity in anti-CD19 CAR T-cell therapy 84
Hemorrhagic cerebral vasculopathy in Susac syndrome 81
Anti-Ma2-associated limbic encephalitis presenting with transient epileptic amnesia 80
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 76
Generation of a human induced pluripotent stem cell line (CIBIOi007-A) from a Lafora disease patient 73
Neurological Manifestations of Long COVID: A Single-Center One-Year Experience [Response to Letter] 71
The challenge of ultra-rarity: Dual diagnosis of Lafora disease and developmental encephalopathies linked to TRIO and SHANK3 pathogenic variants 71
Neurofilament Light Chain as a Biomarker of Disease Progression in Lafora Disease 68
Empagliflozin Repurposing for Lafora Disease: A Pilot Clinical Trial and Preclinical Investigation of Novel Therapeutic Targets 68
Impact of neurotoxicity and steroid therapy on cancer progression-free survival in lymphoma patients treated with anti-CD19 CAR T cells 67
Syndrome of inappropriate antidiuresis as a maladaptive stress response shared by coronavirus disease 2019 and other cytokine storm disorders 64
Sleep and Awake EEG Findings in a Patient with Lafora Disease: From Presymptomatic to Overt Disease Stage 58
New therapeutic strategies for Lafora disease: Evaluation of the safety, efficacy, pharmacokinetics and metabolomic profile of intravenous VAL-1221 treatment 55
Letter to the Editor: “Record-Linkage in Population Studies on Epilepsy: Pros and Cons” 46
Risk of SUDEP during infancy 40
Genome-wide association meta-analyses of drug-resistant epilepsy 18
Antiseizure medication use in pregnancy and the risk of poor fetal growth in the EURAP international registry: a prospective cohort study 16
Exploring pathways leading to drug-resistant epilepsy for patients with cryptogenic new onset refractory status epilepticus 15
Oligogenic inheritance in epilepsy: A systematic exome-wide analysis 15
On-site exposure to clinical epilepsy practice for experimental scientists engaged in epilepsy research: A pilot study by the ILAE commission on neurobiology 14
Claustrum Involvement in New Onset Refractory Status Epilepticus: A Systematic Review 13
Post-Ictal aphasia in focal Epilepsy: Speech-language pathologist Perspectives and insights 11
Neuropsychological functioning and progression in Lafora disease 11
Extreme cryptogenic new onset refractory status epilepticus/febrile infection-related epilepsy syndrome: Evidence of profound neuroinflammation and neuronal injury 10
null 1
Totale 10.393
Categoria #
all - tutte 29.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.541


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022583 0 0 0 73 51 26 11 61 36 107 132 86
2022/2023889 81 84 34 67 94 76 32 53 165 38 121 44
2023/2024439 16 42 36 56 38 81 16 57 12 42 24 19
2024/20251.631 69 197 113 99 153 72 72 53 31 198 164 410
2025/20265.239 701 550 399 458 380 179 506 199 878 392 298 299
2026/2027972 248 263 400 61 0 0 0 0 0 0 0 0
Totale 10.393